CVS Health Corporation (CVS) has a consensus analyst rating of Buy, based on 41 analysts covering the stock. Of those, 35 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for CVS is $94.50, representing a +21.7% upside from the current price of $77.62. Price targets range from a low of $90.00 to a high of $101.00.
